These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31815758)

  • 1. PPARγ is a gatekeeper for extracellular matrix and vascular cell homeostasis: beneficial role in pulmonary hypertension and renal/cardiac/pulmonary fibrosis.
    Kökény G; Calvier L; Legchenko E; Chouvarine P; Mózes MM; Hansmann G
    Curr Opin Nephrol Hypertens; 2020 Mar; 29(2):171-179. PubMed ID: 31815758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARγ Activation.
    Calvier L; Boucher P; Herz J; Hansmann G
    Circ Res; 2019 Jun; 124(12):1778-1785. PubMed ID: 31023188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARγ and TGFβ-Major Regulators of Metabolism, Inflammation, and Fibrosis in the Lungs and Kidneys.
    Kökény G; Calvier L; Hansmann G
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the Metabolic Master Regulator PPARγ: A Potential PIOneering Therapy for Pulmonary Arterial Hypertension.
    Hansmann G; Calvier L; Risbano MG; Chan SY
    Am J Respir Cell Mol Biol; 2020 Feb; 62(2):143-156. PubMed ID: 31577451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension.
    Hennigs JK; Cao A; Li CG; Shi M; Mienert J; Miyagawa K; Körbelin J; Marciano DP; Chen PI; Roughley M; Elliott MV; Harper RL; Bill MA; Chappell J; Moonen JR; Diebold I; Wang L; Snyder MP; Rabinovitch M
    Circ Res; 2021 Feb; 128(3):401-418. PubMed ID: 33322916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARγ Links BMP2 and TGFβ1 Pathways in Vascular Smooth Muscle Cells, Regulating Cell Proliferation and Glucose Metabolism.
    Calvier L; Chouvarine P; Legchenko E; Hoffmann N; Geldner J; Borchert P; Jonigk D; Mozes MM; Hansmann G
    Cell Metab; 2017 May; 25(5):1118-1134.e7. PubMed ID: 28467929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
    Liu Y; Tian XY; Mao G; Fang X; Fung ML; Shyy JY; Huang Y; Wang N
    Hypertension; 2012 Dec; 60(6):1471-8. PubMed ID: 23108648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension.
    Hansmann G; de Jesus Perez VA; Alastalo TP; Alvira CM; Guignabert C; Bekker JM; Schellong S; Urashima T; Wang L; Morrell NW; Rabinovitch M
    J Clin Invest; 2008 May; 118(5):1846-57. PubMed ID: 18382765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
    Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
    J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARgamma and the pathobiology of pulmonary arterial hypertension.
    Rabinovitch M
    Adv Exp Med Biol; 2010; 661():447-58. PubMed ID: 20204748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmonary Hypertension.
    Calvier L; Herz J; Hansmann G
    JACC Basic Transl Sci; 2022 Feb; 7(2):164-180. PubMed ID: 35257044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor γ attenuates serotonin-induced pulmonary artery smooth muscle cell proliferation and apoptosis inhibition involving ERK1/2 pathway.
    Han X; Chen C; Cheng G; Liang L; Yao X; Yang G; You P; Shou X
    Microvasc Res; 2015 Jul; 100():17-24. PubMed ID: 25937083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ fibrosis inhibited by blocking transforming growth factor-β signaling via peroxisome proliferator-activated receptor γ agonists.
    Deng YL; Xiong XZ; Cheng NS
    Hepatobiliary Pancreat Dis Int; 2012 Oct; 11(5):467-78. PubMed ID: 23060391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARγ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation.
    Legchenko E; Chouvarine P; Borchert P; Fernandez-Gonzalez A; Snay E; Meier M; Maegel L; Mitsialis SA; Rog-Zielinska EA; Kourembanas S; Jonigk D; Hansmann G
    Sci Transl Med; 2018 Apr; 10(438):. PubMed ID: 29695452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostanoid EP
    Li HH; Hsu HH; Chang GJ; Chen IC; Ho WJ; Hsu PC; Chen WJ; Pang JS; Huang CC; Lai YJ
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L349-L359. PubMed ID: 29146573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Egr-1 mediates leptin-induced PPARγ reduction and proliferation of pulmonary artery smooth muscle cells.
    Xie X; Li S; Zhu Y; Liu L; Ke R; Wang J; Yan X; Yang L; Gao L; Zang W; Li M
    Mol Biol Cell; 2018 Feb; 29(3):356-362. PubMed ID: 29212876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis.
    Li CG; Mahon C; Sweeney NM; Verschueren E; Kantamani V; Li D; Hennigs JK; Marciano DP; Diebold I; Abu-Halawa O; Elliott M; Sa S; Guo F; Wang L; Cao A; Guignabert C; Sollier J; Nickel NP; Kaschwich M; Cimprich KA; Rabinovitch M
    Cell Rep; 2019 Jan; 26(5):1333-1343.e7. PubMed ID: 30699358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.